Defects of T-cell effector function and post-thymic maturation in X- linked hyper-IgM syndrome

Journal of Clinical Investigation

Volumn 103, Issue 8, 1999, Pages 1151-1158

  Jain, Ashish ^a   Atkinson, T Prescott ^b   Lipsky, Peter E ^c   Slater, Jay E ^d   Nelson, David L ^a   Strober, Warren ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; EFFECTOR CELL; GENETIC CODE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKAGE;

EID: 0033560934     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5891     Document Type: Article

References (47)

1. Callard, R.E., Armitage, R.J., Fanslow, W.C., and Spriggs, M.K. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today. 14:559-564.
2. Notarangelo, L.D., Duse, M., and Ugazio, A.G. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3:101-122.
3. Fuleihan, R., et al. 1993. Defective expression of CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:2170-2173.
4. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and deSaint Basile, G. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 361:541-543.
5. Allen, R.C., et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:990-993.
6. Aruffo, A., et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
7. Korthauer, U., et al. 1993. Defective expression of T cell CD40 ligand causes X-linked immunodeficiency wirh Hyper-IgM. Nature. 361:539-541.
8. Xu, J., et al. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
9. Han, S., et al. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556-567.
10. Renshaw, B.R., et al. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp Med. 180:1189-1900.
11. Levy, J., et al. 1997. Clinical spectrum of X-Linked hyper-IgM syndrome. J. Pediatr. 131:47-54.
12. Soong, L., et al. 1996. Disruption of CD40-CD40 ligand interaction results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:263-273.
13. Campbell, K.A., et al. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 3:283-289.
14. Seyama, K., et al. 1998. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 7:2421-2434.
15. Grammer, A.C., et al. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:4996-5010.
16. Ramesh, N., et al. 1993. Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal to elevated IgM (HIGMX-1). Int. Immunol. 5:769-773.
17. Mackall, CL, et al. 1995. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after in tensive chemotherapy. N. Engl. J. Med. 332:143-149.
18. Kanof, M.E. 1991. Preparation of human mononuclear cell populations and subpopulations. In Current protocols in immunology. J.E. Coligan, A.M. Kruisebeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. Greene Publishing and Wiley Interscience. New York, NY. 7.1.2-7.1.3.
19. Fuss, I.J., et al. 1996. Disparate CD4+ lamina propia (LP) lymphocytes secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP manifest increased secretion of IL-5. J. Immunol. 157:1261-1270.
20. Holmes, K., and Fowlkes, B.J. 1991, Preparation of cells and reagents for flow cytometry. In Current protocols in immunology. J.E. Coligan, A.M. Kruisebeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. Greene Publishing and Wiley Interscience. New York, NY. 5.3.1-5.3.5.
21. Villa, A., et al. 1994. Organization of the human CD40L gene: implications of molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. USA. 91:2110-2114.
22. Atkinson, T.P., et al. 1998. Leukocyte transfusion-associated granulocyte responses in a patient with X-Iinked hyper-IgM syndrome. J. Clin. Immunol. 18:430-439.
23. Chu, Y.W., et al. 1995. Somatic mutation of human immunoglobulin V genes in the X-linked hyper IgM syndrome. J. Clin. Invest. 95:1389-1393.
24. Grewal, I.S., and Flavell, R.A. 1988. CD40 and CD154 in cell mediated immunity. Annu. Rev. Immunol. 16:111-135,
25. Shu, U., et al. 1995. Activated T cells induce interleukin-12 production fay monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125-1128.
26. Trinchieri, G. 1988. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol 16:365-396.
27. Mackay, C.R. 1993, Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:423-427.
28. Pilarski, L.M., Gillitzer, R., Zola, H., Shortman, K., and Scollay, R. 1989. Definition of the thymic generation lineage by selective expression of high molecular weight isoforms of CD45 (T200). Eur. J. Immunol. 19:589-597.
29. Fujii, Y., Okumura, M., Inada, K., Nakahara, K., Matusda, H. 1992. CD45 isoform expression during T cell development in the thymus. Eur. J. Immunol. 22:1843-1850.
30. Grewal, I.S., Xu, J., and Flavell, R.A. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620.
31. Erkeller-Yuksel, F.M., et al. 1992. Age related changes in human blood lymphocytes subpopulations. J. Pediatr. 120:216-222.
32. Serra, H.M., Krowka, J.F., Ledbetter, J.A., and Pilarski, L.M. 1988. Loss of CD45R(Lp220) represents a post-thymic T cell differentiation event. J. Immunol. 140:1435-1441.
33. Cella, M., et al. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
34. Caux, C., et al. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
35. Kennedy, M.K., et al. 1994. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24:116-123.
36. Kawabe, T., et al. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
37. Defrance, T.B., et al. 1992. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671-682.
38. Gascan, H., Gauchat, J.F., Aversa, G., van Vlasselaer, P., and de Vries, J.E. 1991. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8-13.
39. Agematsu, K., et al. 1998. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J. Clin. Invest. 102:853-860.
40. Stuber, E., Strober, W., and Neurath, M. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interteukin 12 secretion. J. Exp. Med. 183:693-698.
41. Schoenberger, S.P., Toes, R.E., van der Voort, E.I., Offringa, R., and Melief, C.J. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
42. Bennett, S.R., et al. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:478-480.
43. Ridge, J.P., Di Rosa, F., and Matzinger, P. 1988. A conditioned dendritic cell can be a temporal bridge between a CD4+ T- helper and a T-killer cell. Nature. 393:474-478.
44. Ameratunga, R., et al. 1997. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J. Pediatr. 131:147-150.
45. Geha, R.H., et al. 1979. Hyperimmunoglobulin M immunodeficiency. J. Clin. Invest. 64:385-391.
46. Hayward, A.R., et al. 1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977-983.
47. The International Chronic Granulomatous Disease Cooperative Study Group. 1991. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, N. Engl. J. Med. 324:509-516.